Skip to Content
scroll

Xero (ASX: XRO) $75.17

XRO +6.08%; closed higher after trading up as much as 13% intraday, with the market responding positively to stronger FY27 guidance, a higher FY28 revenue aspiration and a A$1bn on-market buyback.

It has been a tough run for XRO over recent years, with the market increasingly focused on the cost of growth, margin pressure and the integration of Melio. However, today’s update provided some encouraging evidence that things are starting to improve.

Key highlights:

  • 1H revenue: NZ$1.75bn, up 46% YoY.
  • International revenue: up 79%, comfortably ahead of expectations.
  • ARPU: NZ$62.21, up 25%.
  • Subscribers: 5.15m, up 12%.
  • FY27 revenue guidance increased to NZ$3.77–3.83bn from NZ$3.62–3.73bn.
  • Adjusted EBITDA guidance narrowed to NZ$880–920m, lifting the bottom end.
  • Xero now sees FY28 revenue above NZ$4.6bn, excluding revenue synergies.
  • Management still expects Melio to reach adjusted EBITDA breakeven in 2H FY28.
  • $1bn buyback will commence from mid-November.

There was plenty of noise beneath the headline numbers. Net profit and free cash flow were weaker, gross margins compressed and the CFO is departing. However, the more important forward-looking indicators were better: stronger payments momentum, higher revenue expectations, improving operating leverage and a clearer pathway for Melio to become less of an earnings drag.

We have owned XRO through a difficult period, but this was an encouraging update. The market has spent the past few years questioning whether growth could translate into stronger profitability and cash generation; today’s result suggests that equation is improving.

MM’s view: The combination of higher revenue guidance, better Melio momentum, improving operating leverage and a substantial buyback gives us greater confidence that XRO is moving back in the right direction.

XRO
MM remains bullish and long XRO ~$75
Add To Hit List
chart
image description
Xero (XRO)
image description

Relevant suggested news and content from the site

Back to top